Literature DB >> 11861393

Targeted inactivation of p53 in human cells does not result in aneuploidy.

Fred Bunz1, Christine Fauth, Michael R Speicher, Annie Dutriaux, John M Sedivy, Kenneth W Kinzler, Bert Vogelstein, Christoph Lengauer.   

Abstract

Because p53 mutation and aneuploidy usually coexist, it has been suggested that p53 inactivation leads to aneuploidy. We have rigorously tested this hypothesis in diploid human cell lines in which p53 was experimentally inactivated by targeted homologous recombination. Cells completely deficient in p53 did not become aneuploid, although a slight tendency toward tetraploidization was observed. No increased rates of numerical or structural chromosomal instabilities were observed in the p53-deficient cells. Rates of sister chromatid exchange and homologous recombination were also unaffected by p53 status. These results show that inactivation of p53 does not, in and of itself, lead to the development of aneuploidy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861393

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  77 in total

1.  Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1.

Authors:  Marina Cotsiki; Rowena L Lock; Yuan Cheng; Grace L Williams; Jean Zhao; David Perera; Raimundo Freire; Alan Entwistle; Erica A Golemis; Thomas M Roberts; Parmjit S Jat; Ole V Gjoerup
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

2.  Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells.

Authors:  Susan M Bailey; Mark A Brenneman; Edwin H Goodwin
Journal:  Nucleic Acids Res       Date:  2004-07-16       Impact factor: 16.971

Review 3.  Genomic instability--an evolving hallmark of cancer.

Authors:  Simona Negrini; Vassilis G Gorgoulis; Thanos D Halazonetis
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03       Impact factor: 94.444

4.  Discriminatory suppression of homologous recombination by p53.

Authors:  Sheng Yun; Chadwick Lie-A-Cheong; Andrew C G Porter
Journal:  Nucleic Acids Res       Date:  2004-12-15       Impact factor: 16.971

5.  Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.

Authors:  Huaxin Si; Erle S Robertson
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity.

Authors:  Sarah Croessmann; Hong Yuen Wong; Daniel J Zabransky; David Chu; D Marc Rosen; Justin Cidado; Rory L Cochran; W Brian Dalton; Bracha Erlanger; Karen Cravero; Berry Button; Kelly Kyker-Snowman; Paula J Hurley; Josh Lauring; Ben Ho Park
Journal:  Breast Cancer Res Treat       Date:  2017-02-11       Impact factor: 4.872

7.  Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.

Authors:  Yang Liu; Nilay S Sethi; Toshinori Hinoue; Barbara G Schneider; Andrew D Cherniack; Francisco Sanchez-Vega; Jose A Seoane; Farshad Farshidfar; Reanne Bowlby; Mirazul Islam; Jaegil Kim; Walid Chatila; Rehan Akbani; Rupa S Kanchi; Charles S Rabkin; Joseph E Willis; Kenneth K Wang; Shannon J McCall; Lopa Mishra; Akinyemi I Ojesina; Susan Bullman; Chandra Sekhar Pedamallu; Alexander J Lazar; Ryo Sakai; Vésteinn Thorsson; Adam J Bass; Peter W Laird
Journal:  Cancer Cell       Date:  2018-04-02       Impact factor: 31.743

Review 8.  Aneuploidy: cells losing their balance.

Authors:  Eduardo M Torres; Bret R Williams; Angelika Amon
Journal:  Genetics       Date:  2008-06       Impact factor: 4.562

Review 9.  Role of prolonged mitotic checkpoint activation in the formation and treatment of cancer.

Authors:  W Brian Dalton; Vincent W Yang
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

10.  p53 suppression overwhelms DNA polymerase eta deficiency in determining the cellular UV DNA damage response.

Authors:  Rebecca R Laposa; Luzviminda Feeney; Eileen Crowley; Sebastien de Feraudy; James E Cleaver
Journal:  DNA Repair (Amst)       Date:  2007-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.